Kura Oncology, Inc. (KURA)
10.20
-0.26
(-2.44%)
USD |
NASDAQ |
Dec 12, 16:00
10.20
0.00 (0.00%)
After-Hours: 20:00
Kura Oncology Shareholders Equity (Quarterly): 242.54M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -274.14M |
| Curis, Inc. | -14.69M |
| AIM ImmunoTech, Inc. | -6.077M |
| Protalix Biotherapeutics, Inc. | 52.91M |
| Armata Pharmaceuticals, Inc. | -95.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 649.38M |
| Total Liabilities (Quarterly) | 406.84M |
| Debt to Equity Ratio | 0.0803 |
| Current Ratio | 5.117 |
| Net Debt Paydown Yield | -0.07% |